| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |